Negotiating Sponsor-Friendly Contracts that Drive CRO Accountability & Performance
VRMM Stage: Foundational Framework | Optimization
Summary
A privately-owned rare disease biotech preparing for a global Phase 3 clinical trial faced significant contract challenges with its CRO.
Misaligned terms created limited leverage to enforce performance, slow responsiveness to operational issues, and exposure to budget overruns.
Seuss+ was engaged to renegotiate contracts, protect the sponsor’s position, and establish governance structures to hold the CRO accountable.
in recovered revenue
of approved change orders completed
CRO responsiveness
What Seuss+ Delivered
Contract Restructuring for Accountability & Performance
Seuss+ designed and negotiated contracts that clearly defined deliverables, improved escalation pathways, and provided the sponsor with control mechanisms to safeguard budget and timelines.
The Risk/Challenge
Inflexible CRO contracts limiting sponsor leverage
Escalation delays due to vague governance structures
Budget risk from change orders and loosely defined scope
Risk of delays impacting regulatory timelines and asset value
The Results
£8M in recovered revenue in the sponsor’s budget
100% of approved change orders completed at no additional cost
CRO responsiveness increased due to linked milestone-based payments
Full transparency achieved on contract terms and budget implications
Governance processes now allow escalation and contract changes in real time
How We Helped
Redefined Sponsor–CRO relationship: Introduced contract structures prioritizing performance-driven deliverables and clear accountability.
Implemented governance pathways: Designed escalation processes to resolve issues quickly and transparently
Renegotiated payment structures: Linked payments to milestone achievement, increasing CRO responsiveness.
Budget oversight protections: Introduced contract language controlling change orders and preventing unapproved cost increases.
Other Related Case Studies
Schedule a consultation now